Target intelligence / Profile preview

Probable ATP-dependent RNA helicase DDX23 (DDX23)

Target
DDX23
Molecular classification
Enzyme, RNA helicase, DEAD-box protein, Spliceosomal protein
01

Overview

Probable ATP-dependent RNA helicase DDX23 (DDX23) is a member of the DEAD box protein family characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif and functions as a putative RNA helicase[1][3][5]. DDX23 is a core component of the U5 small nuclear ribonucleoprotein (snRNP) complex and plays an essential role in nuclear pre-mRNA splicing by facilitating conformational changes in the spliceosome, particularly enabling the transition to the activated B complex[1][7]. Its phosphorylation by SRPK2 is critical for proper spliceosome assembly and for suppressing RNA:DNA hybrids (R-loops), thereby supporting genomic integrity[1]. DDX23 is also implicated in microRNA biogenesis, embryogenesis, spermatogenesis, and general RNA metabolism, with dysfunction linked to neurodevelopmental disorders (e.g., global developmental delay and seizures) and cancer, where it can regulate cancer-associated non-coding RNAs and serve as a candidate biomarker for disease progression[1][3][5][6].

Other names
DEAD-box helicase 23Prp28U5-100KDPRPF28SNRNP100100 kDa U5 snRNP-specific proteinDEAD box protein 23PRP28 homologU5-100kDU5 snRNP-specific 100-kD proteinU5-100Kprp28DEAD (Asp-Glu-Ala-Asp) box polypeptide 23PRP28p homologU5 snRNP 100 kD protein
02

Biological functions

RNA splicing (pre-mRNA splicing)Alteration of RNA secondary structureMaintenance of genomic stability (suppression of RNA:DNA hybrids)Regulation of transcriptional programsGeneral RNA metabolismMicroRNA (miRNA) biogenesis
03

Disease associations

Cancer (notably lung adenocarcinoma and non-small-cell lung cancer)Neurodevelopmental disorders (syndromic neurodevelopmental disorder)Global developmental delay and seizuresPossibly other proliferative or developmental conditions
04

Safety considerations

Broad involvement in RNA metabolism and splicing suggests potential for on-target toxicity if disruptedAny therapeutic modulation must consider essential roles in cell growth, division, and genome stability
05

Biomarkers

Potential prognostic biomarker in lung adenocarcinoma (elevated expression linked to poor prognosis)

Beyond the preview

Go deeper on Probable ATP-dependent RNA helicase DDX23 (DDX23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable ATP-dependent RNA helicase DDX23 (DDX23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call